Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents. (2023)

First Author: Chandasana H

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40262-023-01289-5

PubMed Identifier: 37603217

Publication URI: http://europepmc.org/abstract/MED/37603217

Type: Journal Article/Review

Volume: 62

Parent Publication: Clinical pharmacokinetics

Issue: 10

ISSN: 0312-5963